Insights

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

Luis Diaz-Santana, Head of Ophthalmology at Cambridge Consultants, presented at OIS European Showcase virtual conference. Watch his presentation to hear his thoughts on if Europe really is an innovation powerhouse in ophthalmology.

What is it really like to work at Cambridge Consultants? Here, three senior colleagues look back on their time at the company and the experience of working here.

The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. I’m proud to be part of a team of colleagues dedicated to doing something about it – by creating a guide that is helping innovators switch to alternatives.

We’re thrilled to be a part of the CGT Catapult, working with 20 brilliant companies to accelerate the technology development for cell and gene therapy manufacturing. 

Innovation in drug delivery devices has evolved at a constant pace for 30 years. But what's next? Our belief is that we sit on the cusp of a decade of innovation and commercial opportunity in active implants.

Scale-down models have become a popular development tool, especially in the bioprocessing industry. But how do you make them robust and reproducible?

The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.

Dan Cowen, Senior Consultant at Cambridge Consultants, presented at Drug Delivery to the Lungs (DDL) - Christmas Lectures and talked about the path to a sustainable future for inhalation products. Watch his presentation to learn how sustainability in inhalation products can be achieved whilst maintaining safety and efficacy at the core.

Sustainability emerged as a hot and emotive topic at this year’s Drug Delivery to the Lungs (DDL) conference, read Donal Taylor's thoughts on other key trends that emerged.

Matt Garwood challenges the medical device development status quo. If we embrace a bold, comprehensive response that begins at the concept stage and ends with the device user, it is possible to challenge conventional thinking and change for the better.